Green dye mapping for lymph nodes in vulvar cancer
Treatments studied
Part of Cancer, Women’s health & pregnancy clinical trials.
This study tests using a green dye (called ICG) injected near your vulvar tumor during surgery to help the surgeon see and remove the right lymph nodes. This could help avoid removing too many lymph nodes and reduce side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older.
- You need to have early-stage vulvar cancer that is smaller than 4 cm and hasn't spread to the lymph nodes in your groin.
- Your cancer must be a type called squamous cell carcinoma, with invasion deeper than 1 mm into the skin.
- You must be scheduled for surgery at Tufts Medical Center in Boston.
- Your tumor must be in a location that allows the doctor to inject the dye around it at 3 to 4 sites.
- You cannot be pregnant, and you must be able to give informed consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new way to find and remove the first lymph node that might contain cancer cells in women with large or recurrent vulvar cancer. It uses a special dye to guide the surgeon, which may help improve staging and reduce side effects.
This study compares two methods for finding the first lymph node (sentinel node) that may contain cancer in people with vulvar cancer. It uses a dye called indocyanine green alone or with a radioactive tracer (technetium) to see which approach works better for staging the disease.
This trial tests if an injection of indocyanine green dye can help surgeons find and remove only the key lymph nodes in the armpit during breast cancer surgery. It aims to reduce the need for more extensive lymph node removal.
This trial tests whether using a green dye (called indocyanine green) during minimally invasive surgery can help the surgeon see and remove lymph nodes more effectively for stomach cancer. The dye is injected near the tumor and may improve the accuracy of lymph node removal, which could help reduce the risk of cancer coming back.
This trial tests using a green dye called ICG (indocyanine green) during breast cancer surgery to find the first lymph nodes (sentinel nodes) that cancer may have spread to. It aims to help doctors locate these nodes more accurately, and is for people with early-stage breast cancer that has not yet spread to the lymph nodes.
This study tests a dye that helps surgeons see the first lymph nodes during esophageal cancer surgery. It might help remove fewer lymph nodes and reduce side effects.
Hear when a new Vulva Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.